Dartmouth Joins Clinical Results Transparency Campaign

Hanover — Dartmouth College has become the first academic center in the U.S. to join an advocacy effort aimed at improving transparency in reporting results from clinical trials.

The Geisel School of Medicine and Dartmouth Institute for Health Policy & Clinical Practice both joined the AllTrials Campaign, which calls for all clinical trials to be registered and the results reported.

Launched in January in the United Kingdom, the campaign now includes 48,000 people and more than 250 organizations.

Around half of all clinical trials have not been published, and others have not even been registered, according to the campaign. The groups involved with AllTrials are concerned that information on what was done and what was found in trials could be lost forever, leading to bad treatment decisions and missed opportunities for improving medicine.

In signing onto the campaign, Dartmouth researchers hope to build support among medical centers for making the results of clinical trials more widely known, said Elliott Fisher, director of the Dartmouth Institute.

“Dartmouth is committed to helping doctors, patients and the public make wise decisions about health and health care,” Fisher said in a news release. “Biased, selective or non-publication of clinical trials undermines our ability to understand and communicate the effects of tests and treatments — and it violates the public trust. We urge academic medical centers throughout the world to join AllTrials’ call for the registration and timely full publication of all clinical trial protocols, methods and results.”